Pharmacokinetics of Risankizumab in Asian Healthy Subjects and Patients With Moderate to Severe Plaque Psoriasis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis

por Khatri, Amit, Eckert, Doerthe, Oberoi, Rajneet, Suleiman, Ahmed, Pang, Yinuo, Cheng, Ling, Othman, Ahmed A.
Publicado 2019

Effect of Varying Degrees of Renal Impairment on the Pharmacokinetics of Omecamtiv Mecarbil

por Trivedi, Ashit, Oberoi, Rajneet K., Jafarinasabian, Pegah, Zhang, Hanze, Flach, Stephen, Abbasi, Siddique, Dutta, Sandeep, Lee, Edward
Publicado 2021

Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection

por Kumada, Hiromitsu, Watanabe, Tsunamasa, Suzuki, Fumitaka, Ikeda, Kenji, Sato, Ken, Toyoda, Hidenori, Atsukawa, Masanori, Ido, Akio, Takaki, Akinobu, Enomoto, Nobuyuki, Kato, Koji, Alves, Katia, Burroughs, Margaret, Redman, Rebecca, Pugatch, David, Pilot-Matias, Tami J., Krishnan, Preethi, Oberoi, Rajneet K., Xie, Wangang, Chayama, Kazuaki
Publicado 2017

Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection

por Kumada, Hiromitsu, Watanabe, Tsunamasa, Suzuki, Fumitaka, Ikeda, Kenji, Sato, Ken, Toyoda, Hidenori, Atsukawa, Masanori, Ido, Akio, Takaki, Akinobu, Enomoto, Nobuyuki, Kato, Koji, Alves, Katia, Burroughs, Margaret, Redman, Rebecca, Pugatch, David, Pilot-Matias, Tami J., Krishnan, Preethi, Oberoi, Rajneet K., Xie, Wangang, Chayama, Kazuaki
Publicado 2017

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection

por Toyoda, Hidenori, Chayama, Kazuaki, Suzuki, Fumitaka, Sato, Ken, Atarashi, Tomofumi, Watanabe, Tsunamasa, Atsukawa, Masanori, Naganuma, Atsushi, Notsumata, Kazuo, Osaki, Yukio, Nakamuta, Makoto, Takaguchi, Koichi, Saito, Satoru, Kato, Koji, Pugatch, David, Burroughs, Margaret, Redman, Rebecca, Alves, Katia, Pilot‐Matias, Tami J., Oberoi, Rajneet K., Fu, Bo, Kumada, Hiromitsu
Publicado 2017

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis

por Chayama, Kazuaki, Suzuki, Fumitaka, Karino, Yoshiyasu, Kawakami, Yoshiiku, Sato, Ken, Atarashi, Tomofumi, Naganuma, Atsushi, Watanabe, Tsunamasa, Eguchi, Yuichiro, Yoshiji, Hitoshi, Seike, Masataka, Takei, Yoshiyuki, Kato, Koji, Alves, Katia, Burroughs, Margaret, Redman, Rebecca, Pugatch, David L., Pilot-Matias, Tami J., Krishnan, Preethi, Oberoi, Rajneet K., Xie, Wangang, Kumada, Hiromitsu
Publicado 2017